NFO Alert: From objective to risk, all you need to know about WhiteOak Capital Pharma and Healthcare Fund

livemint.com:

WhiteOak Capital Mutual Fund announced the launch of the WhiteOak Capital Pharma and Healthcare Fund, an open-ended equity scheme investing in the pharma and healthcare sector. The scheme opened for public subscription on January 16, 2024, and will close on January 30, 2024.

The scheme re-opens for continuous sale and repurchase within five business days from the date of allotment. This is an open-ended equity scheme investing in the pharma and healthcare sector.

This product is suitable for investors seeking The investment objective of the scheme is to provide long-term capital appreciation by investing predominantly in equity and equity-related securities of pharma and healthcare companies. There is no assurance that the investment objective of the scheme will be realised.

Investors can invest under the scheme with a minimum investment of ₹500 per plan/option and in multiples of Re 1. There is no upper limit for investment.

Under normal circumstances, the asset allocation of the scheme will be as follows:Indicative allocations (% of total assets)MinimumMaximumEquity and equity-related instruments of pharma and healthcare companies80%100%Very HighEquity and equity-related instruments of companies other than the above0%20%Very HighUnits of REITs and InvITs0%10%Medium to HighDebt securities and money market instruments0%20%Low to Medium To date, many asset management companies (AMCs) have launched such healthcare funds. These include:Mutual Fund HouseName of the Fund5-year returns (in %)DSP Mutual FundDSP Healthcare Fund26.30SBI Mutual Fund SBI Healthcare Opportunities Fund22.33UTI Mutual FundUTI Healthcare Fund21.20Aditya Birla Sun Life Mutual FundAditya Birla Sun Life Pharma & Healthcare Fund-ITI Mutual FundITI Pharma &